Cumberland Pharmaceuticals Inc.: 10-Q filed 2019-08-14

Name: Cumberland Pharmaceuticals Inc.: 10-Q filed 2019-08-14
Creator: Cumberland Pharmaceuticals Inc.

What Cumberland Pharmaceuticals Inc. reported in its quarterly report filed 2019-08-14 (fiscal Q2 2019): 43 published measures, 122 facts as tagged in accession 0001628280-19-010781.

This filing

Form: 10-Q (quarterly report)
Filed: 2019-08-14
Fiscal period: fiscal Q2 2019
Accession: 0001628280-19-010781 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cumberland Pharmaceuticals Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-06-30	107,546,224	USD
At 2018-12-31	112,693,868	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-06-30	53,857,507	USD
At 2018-12-31	57,123,367	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2019-06-30	54,061,023	USD
At 2018-12-31	55,844,767	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2019-06-30	20,951,180	USD
At 2018-12-31	27,938,960	USD
At 2018-06-30	35,906,655	USD
At 2017-12-31	45,412,868	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-549,507	USD	91
2019-01-01 to 2019-06-30	-623,385	USD	181
2018-04-01 to 2018-06-30	-720,688	USD	91
2018-01-01 to 2018-06-30	-3,099,927	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	1,464,926	USD	181
2018-01-01 to 2018-06-30	1,029,675	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	89,070	USD	181
2018-01-01 to 2018-06-30	131,684	USD	181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	11,580,600	USD	91
2019-01-01 to 2019-06-30	23,483,347	USD	181
2018-04-01 to 2018-06-30	10,163,724	USD	91
2018-01-01 to 2018-06-30	18,751,329	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-1,905,428	USD	181
2018-01-01 to 2018-06-30	201,602	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-6,547,278	USD	181
2018-01-01 to 2018-06-30	-10,737,490	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-06-30	4,122,769	USD
At 2018-12-31	4,746,154	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	15,523,628	shares	91
2019-01-01 to 2019-06-30	15,497,989	shares	181
2018-04-01 to 2018-06-30	15,674,954	shares	91
2018-01-01 to 2018-06-30	15,682,348	shares	181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	15,523,628	shares	91
2019-01-01 to 2019-06-30	15,497,989	shares	181
2018-04-01 to 2018-06-30	15,674,954	shares	91
2018-01-01 to 2018-06-30	15,682,348	shares	181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-0.04	USD/shares	91
2019-01-01 to 2019-06-30	-0.04	USD/shares	181
2018-04-01 to 2018-06-30	-0.05	USD/shares	91
2018-01-01 to 2018-06-30	-0.2	USD/shares	181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-0.04	USD/shares	91
2019-01-01 to 2019-06-30	-0.04	USD/shares	181
2018-04-01 to 2018-06-30	-0.05	USD/shares	91
2018-01-01 to 2018-06-30	-0.2	USD/shares	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	4,462	USD	91
2019-01-01 to 2019-06-30	-76,966	USD	181
2018-04-01 to 2018-06-30	4,159	USD	91
2018-01-01 to 2018-06-30	8,318	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-06-30	737,238	USD
At 2018-12-31	771,213	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	760,982	USD	181
2018-01-01 to 2018-06-30	665,309	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-601,715	USD	91
2019-01-01 to 2019-06-30	-778,511	USD	181
2018-04-01 to 2018-06-30	-868,978	USD	91
2018-01-01 to 2018-06-30	-3,321,200	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-06-30	51,932,357	USD
At 2018-12-31	59,116,037	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	91,200	USD	91
2019-01-01 to 2019-06-30	152,111	USD	181
2018-04-01 to 2018-06-30	22,019	USD	91
2018-01-01 to 2018-06-30	40,321	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-06-30	22,317,129	USD
At 2018-12-31	27,804,224	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-06-30	9,539,981	USD
At 2018-12-31	11,093,297	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2019-06-30	882,000	USD
At 2018-12-31	784,000	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2019-06-30	32,044,234	USD
At 2018-12-31	33,655,099	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2019-06-30	8,427,278	USD
At 2018-12-31	7,844,249	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	1,220,690	USD	181
2018-01-01 to 2018-06-30	1,951,199	USD	181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2019-06-30	10,648,859	USD
At 2018-12-31	12,078,343	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	1,458,366	USD	91
2019-01-01 to 2019-06-30	2,725,967	USD	181
2018-04-01 to 2018-06-30	1,450,390	USD	91
2018-01-01 to 2018-06-30	3,325,329	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-06-30	15,471,070	shares
At 2018-12-31	15,481,497	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2019-06-30	53,688,717	USD
At 2019-03-31	55,190,727	USD
At 2018-12-31	55,570,501	USD
At 2018-06-30	59,670,450	USD
At 2018-03-31	60,874,305	USD
At 2017-12-31	63,921,601	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2019-06-30	3,260,767	USD
At 2019-01-01	3,600,000	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2019-06-30	3,402,112	USD
At 2019-01-01	3,800,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-06-30	6,065,828	USD
At 2018-12-31	2,531,309	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-566,812	USD	91
2019-01-01 to 2019-06-30	-607,230	USD	181
2019-01-01 to 2019-03-31	-40,418	USD	90
2018-04-01 to 2018-06-30	-745,450	USD	91
2018-01-01 to 2018-06-30	-3,137,639	USD	181
2018-01-01 to 2018-03-31	-2,392,189	USD	90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-566,812	USD	91
2019-01-01 to 2019-06-30	-607,230	USD	181
2018-04-01 to 2018-06-30	-745,450	USD	91
2018-01-01 to 2018-06-30	-3,137,639	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	2,528,916	USD	91
2019-01-01 to 2019-06-30	5,198,972	USD	181
2018-04-01 to 2018-06-30	2,334,223	USD	91
2018-01-01 to 2018-06-30	4,664,504	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	2,174,397	USD	181
2018-01-01 to 2018-06-30	1,394,728	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	1,029,708	USD	91
2019-01-01 to 2019-06-30	2,051,353	USD	181
2018-04-01 to 2018-06-30	648,520	USD	91
2018-01-01 to 2018-06-30	1,284,655	USD	181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	43,605	USD	181
2018-01-01 to 2018-06-30	0	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	0	USD	181
2018-01-01 to 2018-06-30	200,909	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	583,029	USD	181
2018-01-01 to 2018-06-30	-2,589,017	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-1,429,484	USD	181
2018-01-01 to 2018-06-30	607,653	USD	181

Inspect the source

Entity: Cumberland Pharmaceuticals Inc. / CIK 0001087294
Captured: 2026-09-20T05:21:29.619Z
SEC response SHA-256: b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))